Literature DB >> 19657773

Individual characterization of stably expanded T cell clones in ankylosing spondylitis patients.

I Z Mamedov1, O V Britanova, A V Chkalina, D B Staroverov, A L Amosova, A S Mishin, M A Kurnikova, I V Zvyagin, Z Y Mutovina, A V Gordeev, S V Khaidukov, G V Sharonov, D A Shagin, D M Chudakov, Y B Lebedev.   

Abstract

Ankylosing spondylitis (AS) is commonly characterized by clonal expansions of T cells. However, these clonal populations are poorly studied and their role in disease initiation and progression remains unclear. Here, we performed mass sequencing of TCR V beta libraries to search for the expanded T cell clones for two AS patients. A number of clones comprising more than 5% of the corresponding TCR V beta family were identified in both patients. For the first time, expanded clones were shown to be stably abundant in blood samples of AS patients for the prolonged period (1.5 and 2.5 years for two patients, correspondingly). These clones were individually characterized in respect to their differentiation status using fluorescent cell sorting with CD27, CD28, and CD45RA markers followed by quantitative identification of each clone within corresponding fraction using real time PCR analysis. Stable clones differed in phenotype and several were shown to belong to the proinflammatory CD27 - /CD28 - population. Their potentially cytotoxic status was confirmed by staining with perforin-specific antibodies. Search for the TCR V beta CRD3 sequences homologous to the identified clones revealed close matches with the previously reported T cell clones from AS and reactive arthritis patients, thus supporting their role in the disease and proposing consensus TCR V beta CDR3 motifs for AS. Interestingly, these motifs were also found to have homology with earlier reported virus-specific CDR3 variants, indicating that viral infections could play role in development of AS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657773     DOI: 10.1080/08916930902960362

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  8 in total

Review 1.  Genetics and the Causes of Ankylosing Spondylitis.

Authors:  Aimee Hanson; Matthew A Brown
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

Review 2.  Functional Genomics and Its Bench-to-Bedside Translation Pertaining to the Identified Susceptibility Alleles and Loci in Ankylosing Spondylitis.

Authors:  Tony J Kenna; Aimee Hanson; Mary-Ellen Costello; Matthew A Brown
Journal:  Curr Rheumatol Rep       Date:  2016-10       Impact factor: 4.592

3.  Single high-dose treatment with glucosaminyl-muramyl dipeptide is ineffective in treating ankylosing spondylitis.

Authors:  Olga V Britanova; Dmitriy B Staroverov; Anna V Chkalina; Alexei A Kotlobay; Ekaterina S Zvezdova; Anna G Bochkova; Dmitriy M Chudakov
Journal:  Rheumatol Int       Date:  2010-11-30       Impact factor: 2.631

Review 4.  Juvenile Spondyloarthritis: What More Do We Know About HLA-B27, Enthesitis, and New Bone Formation?

Authors:  Shi Huan Tay; Joo Guan Yeo; Jing Yao Leong; Salvatore Albani; Thaschawee Arkachaisri
Journal:  Front Med (Lausanne)       Date:  2021-05-20

5.  Quantitative tracking of T cell clones after haematopoietic stem cell transplantation.

Authors:  Ilgar Z Mamedov; Olga V Britanova; Dmitriy A Bolotin; Anna V Chkalina; Dmitriy B Staroverov; Ivan V Zvyagin; Alexey A Kotlobay; Maria A Turchaninova; Denis A Fedorenko; Andrew A Novik; George V Sharonov; Sergey Lukyanov; Dmitriy M Chudakov; Yuri B Lebedev
Journal:  EMBO Mol Med       Date:  2011-03-04       Impact factor: 12.137

6.  Preparing unbiased T-cell receptor and antibody cDNA libraries for the deep next generation sequencing profiling.

Authors:  Ilgar Z Mamedov; Olga V Britanova; Ivan V Zvyagin; Maria A Turchaninova; Dmitriy A Bolotin; Ekaterina V Putintseva; Yuriy B Lebedev; Dmitriy M Chudakov
Journal:  Front Immunol       Date:  2013-12-23       Impact factor: 7.561

7.  Characterization of the T-cell Repertoire after Autologous HSCT in Patients with Ankylosing Spondylitis.

Authors:  E A Komech; I V Zvyagin; M V Pogorelyy; I Z Mamedov; D A Fedorenko; Y B Lebedev
Journal:  Acta Naturae       Date:  2018 Apr-Jun       Impact factor: 1.845

8.  Optimized Peptide-MHC Multimer Protocols for Detection and Isolation of Autoimmune T-Cells.

Authors:  Garry Dolton; Efthalia Zervoudi; Cristina Rius; Aaron Wall; Hannah L Thomas; Anna Fuller; Lorraine Yeo; Mateusz Legut; Sophie Wheeler; Meriem Attaf; Dmitriy M Chudakov; Ernest Choy; Mark Peakman; Andrew K Sewell
Journal:  Front Immunol       Date:  2018-06-29       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.